OrthAlign CEO Eric Timko on the Opportunity for Fast Followers In...

Why It Matters

Understanding emerging regulatory support, financing options, and cyber threats equips med‑tech firms to accelerate product launches and protect value, while investors can pinpoint high‑growth opportunities.

Key Takeaways

• FDA’s new pathways aim to streamline medtech commercialization.
• White Oak 66 will guide startups through regulatory and payer landscapes.
• Cyber‑security breaches highlight urgent need for industry response plans.
• Transcatheter heart‑valve market projected 8.4% CAGR through decade.
• Device Talks webinars offer free expert insights on surgical robotics.

Summary

The Device Talks podcast episode provides a broad snapshot of the current med‑tech landscape, from regulatory shifts and financing to cybersecurity and market growth. Host Tom Le and guests discuss recent events such as the MedTech Innovator Radar Forum, FDA initiatives led by Michelle Tarver, and the launch of White Oak 66, a private‑equity group designed to smooth the path to commercialization for startups. Key insights include the FDA’s renewed commitment to clearer approval pathways, the strategic role of White Oak 66’s founders in navigating CPT coding and payer engagement, and a stark reminder of cyber‑risk after Striker’s recent data‑wipe incident. The episode also highlights a free MassDevice special report forecasting an 8.4% compound annual growth rate for transcatheter heart‑valve devices through the decade. Notable examples feature Tarver’s promise of continued industry collaboration, Striker’s rapid restoration of operations as a potential playbook, and the market forecast authored by analyst Carrie Neptune. The hosts also promote a four‑part surgical‑robotics webinar series, offering free access to experts across soft‑tissue, orthopedic, and ophthalmic robotics. For med‑tech companies and investors, these developments signal both opportunity and responsibility: fast‑follower firms can leverage new FDA pathways and White Oak guidance, while robust cybersecurity and market intelligence become essential competitive differentiators.

Original Description

In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.

In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report.

***

Enjoy the show? Follow [DeviceTalks Weekly](https://devicetalksweekly.castos.com/subscribe) on all major podcast players + Follow us on [YouTube.com/@DeviceTalks](https://www.youtube.com/@DeviceTalks) to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

00:02:30 MedTech Innovator Radar Forum

00:09:30 MassDevice’s Transcatheter Heart Valves Special Report

00:11:08 Stryker operations fully restored after cyberattack

00:14:55 Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe

00:16:30 Former Intuitive EVP Brian Miller joins Sovato as CEO

00:21:18 Former Baxter CEO takes the corner office at Hologic as go-private deal closes

00:26:20 Keynote interview: Eric Timko, CEO, OrthAlign